Careers  |  Sign In  |  Register  |   Twitter

Latest in HIV/AIDS

Reuters Health • The Doctor's Channel Daily Newscast

Single-tablet daily ART regimen maintains high rate of HIV-1 suppression

NEW YORK (Reuters Health) – In a prospective, randomized trial, a single daily tablet containing efavirenz, emtricitabine, and tenofovir (Atripla; Bristol Myers Squibb & Gilead Sciences LLC) maintained viral suppression in HIV-1 infected patients as well as the standard multiple-pill regimen. The...

Latest advances in treating HIV infection

HIV treatment

John Flaherty, MD, Professor of Medicine, Northwestern University, discusses HIV infection, latest trends in treatment and what a hospitalist needs to know. Summary: 1.There is a trend toward early initiation of antiretroviral therapy in HIV, the list of available drugs has expanded and that of first...
NEW YORK (Reuters Health) – Sperm washing and in-vitro fertilization (IVF) with intracytoplasmic sperm infection (ICSI) can safely achieve pregnancy in couples in which the male is HIV-positive, while the female is not, according to findings from a study at Columbia University in New York. “Although...